Nordson Corp
NDSN: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$271.00 | Svwhf | Xjfxsztqz |
Nordson Earnings: Headwinds in Semiconductor and Biopharma End Markets Weigh on Revenue Growth
Narrow-moat-rated Nordson’s fiscal third-quarter adjusted EPS declined by 6% from the prior-year period, from $2.49 to $2.35, as the firm continued to face headwinds in the semiconductor and biopharma end markets. We’ve maintained our $237 fair value estimate, as our slightly more muted near-term revenue growth projections were offset by time value of money.